Walmart Is Selling a $160 Bluetooth Headset for Only $20: 'Absolute Steal'
Walmart Is Selling a $160 Bluetooth Headset for Only $20: 'Absolute Steal' originally appeared on Athlon Sports.
Does saving big on a popular Bluetooth headset sound like something you'd like to do?
Walmart is selling a highly rated G2 Bluetooth headset for only $20 right now. The list price is $160, so buyers are saving a whopping 88%.
The Green version is the color on sale for this low price, and two additional options are selling for just $2 more.
This single-ear Bluetooth earpiece is equipped with an ENC mic as well as HiFi stereo sound. It offers up to 72 hours of talk time, includes a 400mAh charging case, and is compatible with iOS and Android cell phones.
Buyers have rated this Bluetooth headset 4.7 stars out of five.
"This headset was very easy to connect, and the sound is crystal clear. We got this to replace a lower-quality headset and were happy with the performance. The battery life is great, and this was priced very reasonably. We will likely get another one for our daughter to use!" says a reviewer.
"This Bluetooth earbud is totally awesome. The best sound, ease of use is outstanding, and the battery life is excellent. Mine lasted over two days in constant use. This is a high-quality device and was an absolute steal. Best ear device I've ever used," says another.
Buyers are raving about this headset.
"I've been using this Bluetooth earpiece for a few days, and it works great. The sound is clear, and the mic picks up my voice well. Very light and fits comfortably on my ear. The battery lasts a long time. Great price for what it offers," says a reviewer.
"I am very happy with this Bluetooth headset! Very reliable, the battery is very lasting and I like the fact that it charges very quickly," says another.
Walmart offers free shipping on orders of $35 or more. Walmart+ members get free shipping with no minimum order. This item qualifies for free 30-day returns.
Walmart Is Selling a $160 Bluetooth Headset for Only $20: 'Absolute Steal' first appeared on Athlon Sports on Jul 8, 2025
This story was originally reported by Athlon Sports on Jul 8, 2025, where it first appeared.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 minutes ago
- Yahoo
Crypto firm Bitcoin Standard to go public through deal with Cantor-backed SPAC
(Reuters) -Crypto firm Bitcoin Standard Treasury Company is aiming to list on the Nasdaq through a merger with a Cantor Fitzgerald-backed blank check vehicle, the company said on Thursday. The move comes roughly four months after Cantor teamed up with Tether and Softbank for a $3.6 billion crypto venture to buy bitcoin. Bitcoin Standard will go public with over 30,000 bitcoin on its balance sheet, which would it the 4th largest listed bitcoin treasury, it said. The deal is expected to close in the fourth quarter of 2025. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 minutes ago
- Yahoo
AITX Signs $5 Million Revolving Credit Term Sheet to Fuel Momentum
Due Diligence Completed with Experienced Lending Partner as Company Moves Towards Non-Dilutive Financing to Support Sales Growth Detroit, Michigan--(Newsfile Corp. - July 17, 2025) - Artificial Intelligence Technology Solutions, Inc. (OTCID: AITX) (the "Company"), a global leader in AI-driven security and productivity solutions, today announced that CEO and Steve Reinharz has signed a term sheet, subject to a definitive executed agreement, outlining a revolving credit facility of up to $5 million. The facility, once finalized, will be provided by a well-established lender with more than 20 years of operating history. The term sheet was executed following extensive due diligence completed by both parties as well as several term sheet adjustments prior to mutual acceptance. To view an enhanced version of this graphic, please visit: The proposed facility is structured with an interest rate of approximately 14% plus related fees, featuring interest-only payments plus fees for the first year. This arrangement, once completed, is expected to offer AITX flexible access to growth capital without the immediate burden of principal repayment. "Careful selection and negotiation lead us to this point with this lender. The credit facility, when closed, will allow us to build inventory and finished goods without the need to fund inventory from stock sales to our institutional investor commonly understood as dilution," commented Reinharz. "I appreciate the diligence both parties demonstrated throughout this process, and we hope to announce completion of this deal in the next few weeks." Investors and stakeholders interested in learning more about AITX, its subsidiaries, and its strategic growth plans are encouraged to download the Company's latest Corporate Profile, available at AITX, through its primary subsidiary, Robotic Assistance Devices, Inc. (RAD-I), is redefining the nearly $50 billion (US) security and guarding services industry[1] through its broad lineup of innovative, AI-driven Solutions-as-a-Service business model. RAD-I solutions are specifically designed to provide cost savings to businesses of between 35%-80% when compared to the industry's existing and costly manned security guarding and monitoring model. RAD-I delivers these tremendous cost savings via a suite of stationary and mobile robotic solutions that complement, and at times, directly replace the need for human personnel in environments better suited for machines. All RAD-I technologies, AI-based analytics and software platforms are developed in-house. The Company's operations and internal controls have been validated through successful completion of its SOC 2 Type 2 audit, reinforcing the Company's credibility with enterprise and government clients who require strict data protection and security compliance. RAD has a prospective sales pipeline of over 35 Fortune 500 companies and numerous other client opportunities. RAD expects to continue to attract new business as it converts its existing sales opportunities into deployed clients generating a recurring revenue stream. Each Fortune 500 client has the potential of making numerous reorders over time. AITX is an innovator in the delivery of artificial intelligence-based solutions that empower organizations to gain new insight, solve complex challenges and fuel new business ideas. Through its next-generation robotic product offerings, AITX's RAD-I, RAD-R, RAD-M and RAD-G companies help organizations streamline operations, increase ROI, and strengthen business. AITX technology improves the simplicity and economics of patrolling and guard services and allows experienced personnel to focus on more strategic tasks. Customers augment the capabilities of existing staff and gain higher levels of situational awareness, all at drastically reduced cost. AITX solutions are well suited for use in multiple industries such as enterprises, government, transportation, critical infrastructure, education, and healthcare. To learn more, visit and or follow Steve Reinharz on X @SteveReinharz. CAUTIONARY DISCLOSURE ABOUT FORWARD-LOOKING STATEMENTS The information contained in this publication does not constitute an offer to sell or solicit an offer to buy securities of Artificial Intelligence Technology Solutions, Inc. (the "Company"). This publication contains forward-looking statements, which are not guarantees of future performance and may involve subjective judgment and analysis. The information provided herein is believed to be accurate and reliable, however the Company makes no representations or warranties, expressed or implied, as to its accuracy or completeness. The Company has no obligation to provide the recipient with additional updated information. No information in this publication should be interpreted as any indication whatsoever of the Company's future revenues, results of operations, or stock price. ### Steve Reinharz949-636-7060@SteveReinharz [1] To view the source version of this press release, please visit
Yahoo
2 minutes ago
- Yahoo
Fifty 1 Labs, Inc. (FITY) Sparks AI Breakthrough in Drug Repurposing: Subsidiary Fifty1 AI Labs Announces Strategic Partnership with Intent to Acquire BioSpark AI Technologies
SEATTLE, July 17, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty1 AI Labs, LLC, an innovative subsidiary of Fifty 1 Labs, Inc. (OTC: FITY), is thrilled to announce a strategic partnership with an intent to acquire BioSpark AI Technologies Inc., a Vancouver-based pioneer in advanced AI and large language model (LLM) technologies. Revealed today, this alliance is set to transform drug repurposing by leveraging cutting-edge AI to unlock transformative therapeutic insights from vast volumes of medical literature, advancing functional medicine and preventative care. Unleashing Hidden Insights with AI-Powered Precision This collaboration integrates BioSpark's proprietary AI and LLM platform with Fifty1 AI Labs' advanced predictive modeling to explore and organize extensive case-based medical literature. BioSpark's system automates the extraction, structuring, and indexing of real-world clinical data—covering patient journeys, treatment sequences, and outcomes—eliminating the inefficiencies of manual analysis. This empowers Fifty1 AI Labs to identify overlooked therapeutic patterns in longitudinal medical narratives, case series, and observational reports with unprecedented efficiency and scale. "Combining BioSpark's sophisticated insight engine with our predictive AI platform unlocks a wealth of untapped clinical knowledge," said Paul Arora, CEO of Fifty1 AI Labs. "This partnership, with our intent to acquire BioSpark, accelerates our ability to identify promising drug repurposing candidates, delivering innovative treatments to patients faster and solidifying our leadership in AI-powered functional medicine." A Synergistic Leap Toward Next-Generation Drug Repurposing By merging BioSpark's expertise in converting unstructured clinical data into structured, queryable formats with Fifty1 AI Labs' proprietary Bayesian inference and polypharmacy modeling, this partnership pioneers an advanced approach to drug repurposing, grounded in real-world clinical experiences and enhanced by AI-driven analytics. Fifty1 AI Labs will process, prioritize, and evaluate BioSpark-generated insights to streamline the transition from literature discoveries to clinical trials, focusing on high-potential sectors like performance health, chronic disease prevention, and wellness enhancement. This strategic alliance, with the intent to fully acquire BioSpark, strengthens Fifty1 AI Labs' visionary approach to dominating preventative healthcare through personalized, data-driven strategies and rapid candidate identification. It will fuel the development of repurposed formulations, incorporating proprietary transdermal and sublingual delivery systems optimized for superior patient outcomes. BioSpark's scalable literature mining capabilities will serve as a cornerstone in Fifty1's discovery and formulation processes. A Shared Vision for Human-AI Collaboration Bound by a shared commitment to enhancing human expertise with ethical, transparent AI tools, Fifty1 AI Labs and BioSpark AI Technologies aim to tap into the vast, often-overlooked potential within functional medicine that traditional clinical trials may miss. Through modern AI solutions, this partnership seeks to harness these opportunities securely, effectively, and at scale, while preserving researchers' intuitive judgment. "BioSpark's platform transforms complex clinical data into actionable knowledge for experts," said a BioSpark AI spokesperson. "Partnering with Fifty1 AI Labs, with their intent to acquire our technology, amplifies this impact, driving progress in functional medicine and drug repurposing through our shared vision for human-AI collaboration." About BioSpark AI Technologies Inc. Founded in 2022 in Vancouver, Canada, BioSpark AI Technologies Inc. specializes in organizing and integrating real-world clinical data using proprietary AI and LLM technologies. Holding a U.S. patent (US 20250029734 A1) for its AI system that automates patient journey extraction and structuring from unstructured medical literature, BioSpark enables scalable, precise automation for clinical development, outcomes research, and medical advancements. Learn more at About Fifty1 AI Labs, LLC Based in Seattle, Washington, Fifty1 AI Labs, LLC—a subsidiary of Fifty 1 Labs, Inc. (OTC: FITY)—is at the forefront of AI-driven functional medicine. Dedicated to transforming preventative healthcare and wellness, the company combines predictive AI with deep clinical insights to innovate in drug repurposing and formulation, addressing critical needs in performance health, chronic disease prevention, and personalized medicine. Forward-Looking Statements This press release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the company's future financial and operating performance, business strategy, plans, objectives, expectations regarding future events or performance, and the potential acquisition of BioSpark AI Technologies Inc. These statements are based on current expectations, estimates, forecasts, and projections, and involve known and unknown risks, uncertainties, and other factors that may cause actual results to differ materially from those expressed or implied. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date they are made. The company undertakes no obligation to update or revise any forward-looking statements, except as required by law. For additional details, refer to the company's filings with the Securities and Exchange Commission. Contact: Investor Relations Fifty 1 Labs, Inc. Email: ir@ Phone: (877) 505-5006 Website: Wire Service Contact: IBN Austin, Texas 512.354.7000 Office Editor@
